Computational investigations on the natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy

HIGHLIGHTS

• who: Geethu S Kumar and collaborators from the Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, Uttar Pradesh, India have published the research work: Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy, in the Journal: Life 2022, 12, 659. of 27/04/2022
• what: Programmed death ligand-1 (PD-L1) is a potential target for the suppression of cancer progression.
• how: The authors have utilized the multi-step virtual screening protocol linked with binding free_energy and ADMET . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.